Roche gets emergency approval for combination COVID-19, flu A/B test
September 4, 2020 – Roche (Basel, Switzerland) announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems received Emergency…
Roche
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE Mark
September 2, 2020 – Roche (Basel, Switzerland) announced it will launch a SARS-CoV-2 Rapid Antigen Test in late September for markets accepting the CE Mark….
Roche receives FDA approval of FoundationOne Liquid CDx, comprehensive pan-tumor liquid biopsy test
August 28, 2020 – Roche (Basel, Switzerland) received U.S. Food and Drug Administration (FDA) approval for FoundationOne Liquid CDx, Foundation Medicine’s comprehensive pan-tumor liquid biopsy…
FDA approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)
August 17, 2020 – Roche (Basel, Switzerland) announced that the U.S. Food and Drug Administration (FDA) has approved ENSPRYNG (satralizumab-mwge) as the first and only…
FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults, children
August 10, 2020 – Roche (Basel, Switzerland) received approval from the U.S. Food and Drug Administration (FDA) for Evrysdi (risdiplam) for the treatment of spinal…
Roche receives FDA authorization for Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems
August 06, 2020 – Roche (Basel, Switzerland) announced that the U.S. Food and Drug Administration (FDA) has authorized the cobas EBV test. This is the…
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers